RAYUS Radiology Acquires InHealth Imaging to Expand Puget Sound Presence

RAYUS Radiology, one of the nation’s leading radiology and outpatient imaging providers, announced the acquisition of three InHealth Imaging centers serving the greater Kitsap Peninsula, Olympic Peninsula, and West Puget Sound communities.

This expansion creates a network of 14 outpatient centers providing high-quality diagnostic imaging and interventional radiology services across the Seattle and Puget Sound region.

“Through this partnership, we establish a platform to bring our best-in-class services and quality radiology solutions to the Kitsap and Olympic Peninsula communities and continue to increase access to freestanding imaging centers in the area,” said Kim Tzoumakas, RAYUS Radiology Chief Executive Officer. “We are proud to partner with local, subspecialized radiologists, technologists and care teams that have been serving Puget Sound communities for more than 20 years.”

With the addition of the three centers in Poulsbo, Bremerton and Port Orchard, RAYUS Radiology will provide the full spectrum of imaging including MRI, CT, 3D mammography and Breast biopsy, Ultrasound and X-ray, Nuclear medicine, Bone densitometry (DXA) and image-guided pain injections.

“We share so many things in common – from the way our radiologists connect with referring providers to our care teams’ commitment to personalized, high quality patient care,” said Manfred Henne, MD, PhD, radiologist and founder of InHealth Imaging. “At a time when patients and providers are seeking high-quality, high-value outpatient imaging and radiology options close to home, this partnership positions us to lead the way in providing a full range of state-of-the-art imaging and interventional radiology services and allows us to continue delivering high-quality local imaging care with the same subspecialized radiologists, staff and locations.

“We are honored to be able to provide the highest quality imaging services as a part of RAYUS in our freestanding centers which allows us to offer affordable rates to our patients,” said Dr. Henne.

As the nation’s leader in outpatient-based diagnostic imaging and related services, RAYUS Radiology manages more than 145 centers in 22 states – including 14 centers serving Seattle and the Puget Sound. RAYUS Radiology combines the strength and efficiency of a robust national network with the flexibility and expertise of local partnerships. Each year, more than one million patients and their referring clinicians turn to RAYUS Radiology for high-quality, patient-centered and highly accessible care through its community-based multi-modality diagnostic imaging centers.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”